Market opportunities lie in enhancing risk-based V&V planning, focusing on DQ, IQ, OQ, and PQs to address cGMP deficiencies and regulatory expectations. By aligning with FDA, ICH, and ISO standards, ...

Market opportunities arise in providing solutions for cGMP software verification and validation, addressing increased FDA scrutiny. Demand exists for expertise in FDA guidelines, risk management ...

Embrace Computer Software Assurance (CSA) for modern life-sciences by focusing on meaningful evidence rather than burdensome documentation. This approach enhances efficiency, aligns with FDA ...

Explore how multi-angle light scattering enhances biosimilar analysis by delivering accurate molecular weight and size ...

Discover how advanced detectors are driving improvements in biopharma quality assurance by enhancing precision across ...

Successful implementation requires modern healthcare infrastructure, including reliable electricity, high-speed internet ...

Robotics is poised for steady growth in 2026. Consider PATH, NVDA, CDNS and ISRG for potential market dominance across sectors.

Siemens highlighted its long-standing partnership with Nvidia at CES 2026 as the two firms develop the Industrial AI ...

Expect the unexpected, the saying goes, and that was certainly true in 2025. President Donald Trump was a major source of global and domestic disruption, but the year’s instability was also driven by ...

Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world ...

At CES 2026, Siemens’ keynote marked a new era of technology for industry and infrastructure, showcasing how customers and ...